When samples were tested against Stx1, a similar low frequency of reactive samples was observed in all clinical groups (Fig. 2A) (HUS = 5%, HUSrec = 14%, NHC = 8%; p = 0.55, Chi-square test). This evidence concerns the gene STX1A and hemolytic-uremic syndrome.